Clinical Trial Update: A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating BGM0504 for Type 2 diabetes in Indonesia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Type 2 Diabetes (T2DM) | Phase 3 | Status: RECRUITING